Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2014; 35(02): 136-139
DOI: 10.4103/0971-5851.138953
POSITION PAPER

Indian Council of Medical Research consensus document for the management of buccal mucosa cancer

Goura Kishor Rath
Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India
,
Purvish M Parikh
Department of Medical Oncology, Precision Medicine and Clinical Research, Asian Institute of Oncology, Somaiya Hospital, Mumbai, India
,
Shelley Hukku
Department of Radiation Oncology, BLK Super Speciality Hospital, New Delhi, India
,
Balakrishnan Rajan
Department of Radiation Oncology, Regional Cancer Centre, Trivandrum, Kerala, India
,
Sandeep Kumar
Department of Surgery, All India Institute of Medical Sciences, Bhopal, India
,
Hemant Malhotra
Division of Medical Oncology, Department of Medicine, RK Birla Cancer Center, SMS Medical College Hospital, Jaipur, India
,
Seenu Vuthaluru
Department of Surgery, All India Institute of Medical Sciences, New Delhi, India
,
Daya Nand Sharma
Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India
,
Amish Vora
Department of Medical Oncology, Max Super Speciality Hospital, Saket, New Delhi, India
,
Deepak Kumar Shukla
ndian Council of Medical Research, New Delhi, India
,
Tanvir Kaur
ndian Council of Medical Research, New Delhi, India
,
Ajeet Kumar Gandhi
Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
19 July 2021

© 2014. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 National Cancer Registry Programme, Indian Council of Medical Research : T0 hree year report of population based cancer registries 2009-2011. Available from : h0 ttp://www.pbcrindia.org/. [Last accessed on 2014 Jun 16].
  • 2 National Cancer Registry Programme, Indian Council of Medical Research : C0 onsolidated report of Hospital Based Registries 2007-2011. Available from : h0 ttp://www.hbcrindia.org/. [Last accessed on 2014 Jun 16].
  • 3 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008 : G0 LOBOCAN 2008. Int J Cancer 2010;127:2893-917.
  • 4 GLOBOCAN 2012 : E0 stimated cancer incidence, prevalence and mortality worldwide in 2012. http://www.globocan.iarc.fr/Pages/fact_sheets_population.aspx. [Last accessed on 2014 Jun 16].
  • 5 Krishnamurthi S, Shanta V, Sastri DV. Combined therapy in buccal mucosal cancers. Radiology 1971;99:409-15.
  • 6 Bahadur S, Kumar S, Tandon DA, Rath GK, De S. Combined therapy in advanced head and neck cancers. J Laryngol Otol 1992;106:412-5.
  • 7 Iype EM, Pandey M, Mathew A, Thomas G, Sebastian P, Nair MK. Oral cancer among patients under the age of 35 years. J Postgrad Med 2001;47:171-6.
  • 8 Badakh DK, Grover AH. The efficacy of postoperative radiation therapy in patients with carcinoma of the buccal mucosa and lower alveolus with positive surgical margins. Indian J Cancer 2005;42:51-6.
  • 9 Yeole BB, Ramanakumar AV, Sankaranarayanan R. Survival from oral cancer in Mumbai (Bombay), India. Cancer Causes Control 2003;14:945-52.
  • 10 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7 th ed. New York, NY : S0 pringer; 2010.
  • 11 Mishra RC, Parida G, Mishra TK, Mohanty S. Tumour thickness and relationship to locoregional failure in cancer of the buccal mucosa. Eur J Surg Oncol 1999;25:186-9.
  • 12 Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
  • 13 Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52.
  • 14 Pederson AW, Salama JK, Witt ME, Stenson KM, Blair EA, Vokes EE, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol 2011;34:356-61.
  • 15 Tayier A, Hayashi K, Yoshimura R. Low-dose-rate interstitial brachytherapy preserves good quality of life in buccal mucosa cancer patients. J Radiat Res 2011;52:655-9.
  • 16 Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC) : a0 n update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14.
  • 17 Dattatreya S, Goswami C. Cetuximab plus radiotherapy in patients with unresectable locally advanced squamous cell carcinoma of head and neck region - a open labelled single arm phase II study. Indian J Cancer 2011;48:154-7.
  • 18 Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer : a0 meta-analysis. Lancet 2006;368:843-54.
  • 19 Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695-704.
  • 20 Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-15.
  • 21 Agarwal JP, Nemade B, Murthy V, Ghosh-Laskar S, Budrukkar A, Gupta T, et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol 2008;89:51-6.
  • 22 Vermorken JB, Trigo J, Hitt R, Koralewski P, Diaz-Rubio E, Rolland F, et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007;25:2171-7.